Neonc Technologies Holdings (NTHI) EBT (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly EBT of -$8.0 million for Q1 2026, up 75.17% year-over-year from -$4.6 million in Q1 2025, and up 46.67% quarter-over-quarter from -$15.0 million in Q4 2025.
Neonc Technologies Holdings (NTHI) EBT (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported EBT for 3 consecutive years, with -$8.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 75.17% year-over-year to -$8.0 million; the TTM figure through Mar 2026 stood at -$36.5 million (up 0.83% YoY), while the FY2025 annual figure was -$82.2 million, down 347.39% from the prior year.
- EBT climbed to -$8.0 million in Q1 2026 per NTHI's latest filing, from -$15.0 million in the prior quarter.
- Across five years, EBT topped out at -$382160.0 in Q2 2024 and bottomed at -$32.2 million in Q1 2025.
- Historically, EBT has averaged -$8.5 million across 3 years, with a median of -$5.8 million in 2025.
- Annual changes were most pronounced in 2025 — EBT tumbled 1409.9% — and 2026, when it soared 75.17%.
- Neonc Technologies Holdings' EBT stood at -$2.1 million in 2024, then sank by 610.37% to -$15.0 million in 2025, then surged by 46.67% to -$8.0 million in 2026.
- Business Quant data shows NTHI's EBT at -$8.0 million in Q1 2026, -$15.0 million in Q4 2025, and -$7.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -13.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.94 Mn |
| Mar 31, 2026 | -7.99 Mn |
| Dec 31, 2025 | -14.97 Mn |
| Sep 30, 2025 | -7.80 Mn |
| Jun 30, 2025 | -5.77 Mn |
| Mar 31, 2025 | -32.16 Mn |
| Dec 31, 2024 | -2.11 Mn |
| Sep 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -382,160.00 |
| Mar 31, 2024 | -2.94 Mn |